Difluoromethylornithine
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 15, 2017 (NCT03077477)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Mammalian polyamine transporterINHIBITOR
Mammalian polyamine transporter inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- amxt 1501
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03077477 | Phase 1 | Apr 15, 2017 | Aminex Therapeutics, Inc., IQVIA, Novella Clinical |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aminex Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2017 |
| IQVIA | For profit | 1 | 0 | 1 | 2017 |
| Novella Clinical | For profit | 1 | 0 | 1 | 2017 |
3 organizations
Page 1 / 1